Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection
出版年份 2021 全文链接
标题
Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2021-12-23
DOI
10.1093/jac/dkab491
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379
- (2020) Jan Martin Berke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection
- (2020) Fabien Zoulim et al. GASTROENTEROLOGY
- Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A–H clinical isolates and core site-directed mutants in vitro
- (2020) Thierry Verbinnen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antiviral Activity and Pharmacokinetics of the HBV Capsid Assembly Modulator GLS4 in Patients with Chronic HBV Infection
- (2020) Hong Zhang et al. CLINICAL INFECTIOUS DISEASES
- A Five-in-One First-in-Human Study To Assess Safety, Tolerability, and Pharmacokinetics of RO7049389, an Inhibitor of Hepatitis B Virus Capsid Assembly, after Single and Multiple Ascending Doses in Healthy Participants
- (2020) Sheng Feng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection
- (2019) Man Fung Yuen et al. GASTROENTEROLOGY
- FRI-180-JNJ-64530440, a novel capsid assembly modulator: single- and multiple-ascending dose safety, tolerability and pharmacokinetics in healthy volunteers
- (2019) Thomas Kakuda et al. JOURNAL OF HEPATOLOGY
- A First-in-Human Trial of GLS4, a Novel Inhibitor of Hepatitis B Virus Capsid Assembly, following Single- and Multiple-Ascending-Oral-Dose Studies with or without Ritonavir in Healthy Adult Volunteers
- (2019) Nan Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial
- (2019) Man-Fung Yuen et al. Lancet Gastroenterology & Hepatology
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- RO7049389, a core protein allosteric modulator, demonstrates robust anti-HBV activity in chronic hepatitis B patients and is safe and well tolerated
- (2018) E. Gane et al. JOURNAL OF HEPATOLOGY
- Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy
- (2018) Meng-Lan Wang et al. Infectious Diseases
- Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients
- (2018) Barbara Testoni et al. JOURNAL OF HEPATOLOGY
- Hepatitis B cure: From discovery to regulatory approval
- (2017) Anna S. Lok et al. HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)
- (2014) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
- (2013) Danny Ka-Ho Wong et al. Clinical Gastroenterology and Hepatology
- Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B
- (2010) Patrick Marcellin et al. LIVER INTERNATIONAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started